Effective vaccine for lassa fever

Journal of Virology

Volumn 74, Issue 15, 2000, Pages 6777-6783

  Fisher Hoch, S P ^a,b   Hutwagner, L ^a,c   Brown, B ^a,d   McCormick, J B ^a,e  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b Fondation Marcel Mérieux ^*  (France)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e SANOFI PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ANTIBODY; VIRUS PROTEIN; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; INFECTION PREVENTION; LASSA FEVER; MACACA; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VACCINIA VIRUS;

ANIMALS; ANTIBODIES, VIRAL; LASSA FEVER; LASSA VIRUS; MACACA FASCICULARIS; MACACA MULATTA; VACCINATION; VACCINES, SYNTHETIC; VIRAL LOAD; VIRAL STRUCTURAL PROTEINS; VIRAL VACCINES; VIREMIA;

EID: 0033910665     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.15.6777-6783.2000     Document Type: Article

References (41)

1. Auperin, D. D., J. J. Esposito, J. V. Lange, S. P. Bauer, J. Knight, D. R. Sasso, and J. B. McCormick. 1988. Construction of a recombinant vaccinia virus expressing the Lassa virus glycoprotein gene and protection of guinea pigs from a lethal Lassa virus infection. Virus Res. 9:233-248.
2. Auperin, D. D., D. R. Sasso, and J. B. McCormick. 1986. Nucleotide sequence of the glycoprotein gene and intergenic region of the Lassa virus S genome RNA. Virology 154:155-167.
3. Bachmann, M. F., and R. M. Zinkernagel. 1997. Neutralizing antiviral B cell responses. Annu. Rev. Immunol. 15:235-270.
4. Baize, S., E. M. Leroy, M. C. Georges-Courbot, M. Capron, J. Lansoud-Soukate, P. Debre, S. P. Fisher-Hoch, J. B. McCormick, and A. J. Georges. 1999. Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients. Nat. Med. 5:423-426.
5. Baldridge, J. R., and M. J. Buchmeier. 1992. Mechanisms of antibody-mediated protection against lymphocytic choriomeningitis virus infection: mother-to-baby transfer of humoral protection. J. Virol. 66:4252-4257.
6. Baldridge, J. R., T. S. McGraw, A. Paoletti, and M. J. Buchmeier. 1997. Antibody prevents the establishment of persistent arenavirus infection in synergy with endogenous T cells. J. Virol. 71:755-758.
7. Bloch, A. 1978. A serological survey of Lassa fever in Liberia. Bull. W. H. O. 56:811-813.
8. Clegg, J. C., and G. Lloyd. 1987. Vaccinia recombinant expressing Lassa-virus internal nucleocapsid protein protects guineapigs against Lassa fever. Lancet ii:186-188.
9. Cummins, D., D. Bennett, S. P. Fisher-Hoch, B. Farrar, and J. B. McCormick. 1989. Electrocardiographic abnormalities in patients with Lassa fever. J. Trop. Med. Hyg. 92:350-355.
10. Cummins, D., S. P. Fisher-Hoch, K. J. Walshe, I. J. Mackie, J. B. McCormick, D. Bennett, G. Perez, B. Farrar, and S. J. Machin. 1989. A plasma inhibitor of platelet aggregation in patients with Lassa fever. Br. J. Haematol. 72:543-548.
11. Cummins, D., J. B. McCormick, D. Bennett, J. A. Samba, B. Farrar, S. J. Machin, and S. P. Fisher-Hoch. 1990. Acute sensorineural deafness in Lassa fever. JAMA 264:2093-2096.
12. Di Simone, C., and M. J. Buchmeier. 1995. Protection of mice from lethal LCMV infection by a reconstituted glycoprotein vaccine, p. 33-37. In Vaccines. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
13. Djavani, M., I. S. Lukashevich, and M. S. Salvato. 1998. Sequence comparison of the large genomic RNA segments of two strains of lymphocytic choriomeningitis virus differing in pathogenic potential for guinea pigs. Virus Genes 17:151-155.
14. Djavani, M., I. S. Lukashevich, A. Sanchez, S. T. Nichol, and M. S. Salvato. 1997. Completion of the Lassa fever virus sequence and identification of a RING finger open reading frame at the L RNA 5′ end. Virology 235:414-418.
15. Fisher-Hoch, S. P. 1993. Stringent precautions are not advisable when caring for patients with viral haemorrhagic fevers. Rev. Med. Virol. 3:7-13.
16. Fisher-Hoch, S. P., J. B. McCormick, D. D. Auperin, B. G. Brown, M. Castor, G. Perez, S. Ruo, A. Conaty, L. Brammer, and S. Bauer. 1989. Protection of rhesus monkeys from fatal Lassa fever by vaccination with a recombinant vaccinia virus containing the Lassa virus glycoprotein gene. Proc. Natl. Acad. Sci. USA 86:317-321.
17. Fisher-Hoch, S. P., J. B. McCormick, D. Sasso, and R. B. Craven. 1988. Hematologic dysfunction in Lassa fever. J. Med. Virol. 26:127-135.
18. Fisher-Hoch, S. P., S. W. Mitchell, D. R. Sasso, J. V. Lange, R. Ramsey, and J. B. McCormick. 1987. Physiological and immunologic disturbances associated with shock in a primate model of Lassa fever. J. Infect. Dis. 155:465-474.
19. Fisher-Hoch, S. P., O. Tomori, A. Nasidi, G. I. Perez Oronoz, Y. Fakile, L. Hutwagner, and J. B. McCormick. 1995. Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. Br. Med. J. 311:857-859.
20. Jahrling, P. B., and C. J. Peters. 1984. Passive antibody therapy of Lassa fever in cynomolgus monkeys: importance of neutralizing antibody and Lassa virus strain. Infect. Immun. 44:528-533.
21. Jahrling, P. B., C. J. Peters, and E. L. Stephen. 1984, Enhanced treatment of Lassa fever by immune plasma combined with ribavirin in cynomolgus monkeys. J. Infect. Dis. 149:420-427.
22. Johnson, K. M., J. B. McCormick, P. A. Webb, E. S. Smith, L. H. Elliott, and I. J. King. 1987. Clinical virology of Lassa fever in hospitalized patients. J. Infect. Dis. 155:456-464.
23. Keenlyside, R. A., J. B. McCormick, P. A. Webb, E. Smith, L. Elliott, and K. M. Johnson. 1983. Case-control study of Mastomys natalensis and humans in Lassa virus-infected households in Sierra Leone. Am. J. Trop. Med. Hyg. 32:829-837.
24. Lukashevich, I. S., M. Djavani, K. Shapiro, A. Sanchez, E. Ravkov, S. T. Nichol, and M. S. Salvato. 1997. The Lassa fever virus L gene: nucleotide sequence, comparison, and precipitation of a predicted 250 KDa protein with monospecific antiserum. J. Gen. Virol. 78:547-551.
25. Maiztegui, J., M. Feuillade, and A. Briggiler. 1986. Progressive extension of the endemic area and changing incidence of Argentine hemorrhagic fever. Med. Microbiol. Immunol. 175:149-152.
26. Maiztegui, J. I., K. T. McKee, Jr., J. G. Barrera Oro, L. H. Harrison, P. H. Gibbs, M. R. Feuillade, D. A. Enria, A. M. Briggiler, S. C. Levis, A. M. Ambrosio, N. A. Halsey, and C. J. Peters. 1998. Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever. AHF Study Group. J. Infect. Dis. 177:277-283.
27. McCormick, J. B. 1990. Arenaviruses, p. 1245-1267. In B. N. Fields and D. M. Knipe (ed.), Fields virology. Raven Press, New York, N.Y.
28. McCormick, J. B., I. J. King, P. A. Webb, K. M. Johnson, R. O'Sullivan, E. S. Smith, S. Trippel, and T. C. Tong. 1987. A case-control study of the clinical diagnosis and course of Lassa fever. J. Infect. Dis. 155:445-455.
29. McCormick, J. B., I. J. King, P. A. Webb, C. L. Scribner, R. B. Craven, K. M. Johnson, L. H. Elliott, and R. Belmont Williams. 1986. Lassa fever. Effective therapy with ribavirin. N. Engl. J. Med. 314:20-26.
30. McCormick, J. B., P. A. Webb, J. W. Krebs, K. M. Johnson, and E. S. Smith. 1987. A prospective study of the epidemiology and ecology of Lassa fever. J. Infect. Dis. 155:437-444.
31. Monath, T. P., V. F. Newhouse, G. E. Kemp, H. W. Setzer, and A. Cacciapuoti. 1974. Lassa virus isolation from Mastomys natalensis rodents during an epidemic in Sierra Leone. Science 185:263-265.
32. Morrison, H. G., S. P. Bauer, J. V. Lange, J. J. Esposito, J. B. McCormick, and D. D. Auperin. 1989. Protection of guinea pigs from Lassa fever by vaccinia virus recombinants expressing the nucleoprotein or the envelope glycoproteins of Lassa virus. Virology 171:179-188.
33. Morrison, H. G., C. S. Goldsmith, H. L. Regnery, and D. D. Auperin. 1991. Simultaneous expression of the Lassa virus N and GPC genes from a single recombinant vaccinia virus. Virus Res. 18:231-241.
34. Price, M. E., S. P. Fisher-Hoch, R. B. Craven, and J. B. McCormick. 1988. A prospective study of maternal and fetal outcome in acute Lassa fever infection during pregnancy. Br. Med. J. 297:584-587.
35. Ruo, S. L., S. W. Mitchell, M. P. Kiley, L. F. Roumillat, S. P. Fisher-Hoch, and J. B. McCormick. 1991. Antigenic relatedness between arenaviruses defined at the epitope level by monoclonal antibodies. J. Gen. Virol. 72:549-555.
36. Trappier, S. G., A. L. Conaty, B. B. Farrar, D. D. Auperin, J. B. McCormick, and S. P. Fisher-Hoch. 1993. Evaluation of the polymerase chain reaction for diagnosis of Lassa virus infection. Am. J. Trop. Med. Hyg. 49:214-221.
37. Wilson, S. M., and J. C. Clegg. 1991. Sequence analysis of the S RNA of the African arenavirus Mopeia: an unusual secondary structure feature in the intergenic region. Virology 180:543-552.
38. Wright, K. E., M. S. Salvato, and M. J. Buchmeier. 1989. Neutralizing epitopes of lymphocytic choriomeningitis virus are conformational and require both glycosylation and disulfide bonds for expression. Virology 171: 417-426.
39. Wright, K. E., R. C. Spiro, J. W. Burns, and M. J. Buchmeier. 1990. Posttranslational processing of the glycoproteins of lymphocytic choriomeningitis virus. Virology 177:175-183.
40. Wulff, H., and J. V. Lange. 1975. Indirect immunofluorescence for the diagnosis of Lassa fever infection. Bull. W. H. O. 52:429-436.
41. Wulff, H., B. M. McIntosh, D. B. Hamner, and K. M. Johnson. 1977. Isolation of an arenavirus closely related to Lassa virus from Mastomys natalensis in south-east Africa. Bull. W. H. O. 55:441-444.